Thursday , July 19 2018
Home / Letter From The Editor / July 2, 2016

July 2, 2016

Jul 2, 2016


I just did a CE program for consultant pharmacists in Lake Mary, Florida. We were discussing the reasons why we may not try to work to perfection with our older patients. One of my colleagues brought up the 5-star ratings and how one of the measurements had to do with using statins in all diabetes patients. Over the past couple of years there have been studies — some published on our website — that could be interpreted as contradictory to that guideline. This led to a discussion on the quality of life versus longevity and how we play such a pivotal role with our patients. This week, Dr Sheri Colberg looks at what really matters in her feature “How to improve Quality of Life not Longevity.”

Another of our contributors, David Kliff, looks at how the use of the SGLT-2 Inhibitor, Empaglifozin, can improve A1Cs while reducing heart risks and possibly improving quality of life.

Announcements: Sunday, July 3, 7PM ET

From “Viewer Will Ryan shares what he has learned about having diabetes; dLife takes a trip on the diabetes bus; Jim Turner quizzes our diabetes knowledge on a fact or fiction diabetes testing procedure.” Sundays live online at at 7 PM ET, 6 PM CT, and 4 PM PT. Keep up on the latest dLife news at


We can make a difference!


Dave Joffe, Editor-in-chief